The BRAFT1799A Mutation is not Associated with Occult Contralateral Carcinoma in Patients with Unilateral Papillary Thyroid Microcarcinoma |
Wan, Han-Feng
(Department of Otorhinolaryngology, Renji Hospistal, School of Medicine, Shanghai Jiao Tong University)
Zhang, Bin (Department of Head and Neck Surgery, Cancer Institute& Hospital, Chinese Academy of Medical Science, Peking Union Medical College) Yan, Dan-Gui (Department of Head and Neck Surgery, Cancer Institute& Hospital, Chinese Academy of Medical Science, Peking Union Medical College) Xu, Zhen-Gang (Department of Head and Neck Surgery, Cancer Institute& Hospital, Chinese Academy of Medical Science, Peking Union Medical College) |
1 | Chow SM, Law SC, Chan JK, et al (2003). Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer, 98, 31-40. DOI |
2 | Cooper DS, Doherty GM, Haugen BR, et al (2009). American thyroid association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-214. DOI |
3 | Hay ID, Grant CS, Taylor WF, et al (1987). Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery, 102, 1088-95. |
4 | Ito Y, Tomoda C, Uruno T, et al (2004). Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg, 28, 1115-21. DOI |
5 | Kebebew E, Weng J, Bauer J, et al (2007). The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg, 246, 466-70; discussion 470-1. DOI |
6 | Koo BS, Lim HS, Lim YC, et al (2010). Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma. Ann Surg Oncol, 17, 1101-5. DOI |
7 | Melck AL, Yip L, Carty SE (2010). The utility of BRAF testing in the management of papillary thyroid cancer. Oncologist, 15, 1285-93. DOI |
8 | Moon WJ, Jung SL, Lee JH, et al (2008). Thyroid study group, Korean society of neuro- and head and neck radiology. benign and malignant thyroid nodules: US differentiationmulticenter retrospective study. Radiology, 247, 762-70. DOI |
9 | Niu LJ, Hao YZ, Zhou CW (2006). Diagnostic value of ultrasonography in thyroid lesions. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 41, 415-18. |
10 | Park SY, Park YJ, Lee YJ, et al (2006). Analysis of differential BRAF (V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci. Cancer, 107, 1831-8. DOI |
11 | Pelizzo MR, Boschin IM, Toniato A, et al (2006). Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol, 32, 1144-8. DOI |
12 | Rossi ED, Martini M, Capodimonti S, et al (2013). BRAF (V600E) mutation analysis on liquid-based cytologyprocessed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. Cancer Cytopathol, 121, 291-7. DOI |
13 | Zhou YL, Zhang W, Gao EL, et al (2012). Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma. Asian Pac J Cancer Prev, 13, 1267-72. DOI |